JAN 12, 2016 9:00 PM PST

Gene that stops tumors may spread colorectal cancer

A gene that is known to suppress the growth and spread of many types of cancer has the opposite effect in some forms of colorectal cancer.

The discovery may lay the foundation for new colorectal cancer treatments.
 
Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States.

“The gene known as Sprouty2 has previously been shown to protect against metastasis, or the spreading of cancer to other parts of the body, in breast, prostate, and liver cancer,” says Sharad Khare, associate professor of research in the University of Missouri School of Medicine’s Division of Gastroenterology and Hepatology and lead author of the study that is published in the journal Oncogene.

“However, our recent molecular studies found that this gene may actually help promote metastasis instead of suppress it.”

For more than three years, researchers have studied Sprouty2 in cancer cell models, mouse models, and human biopsy samples. Using different molecular methods, the researchers found that the gene functions differently in colorectal cancer than in other types of cancers.

Sprouty2 is known to block molecular circuits to prevent cancer cells from growing and spreading to other parts of the body. However, in colorectal cancer, Sprouty2 may increase the metastatic ability of cancer cells instead of suppress it. Khare believes this occurs when the gene is up-regulated, or supercharged.

Cancer deaths attributed to colorectal cancer are mainly due to tumor recurrence and metastasis to other organs. Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States, according to the American Cancer Society. It’s estimated that the lifetime risk of developing colorectal cancer is about 1 in 20.

“This finding is a very significant step in our understanding of metastasis in colorectal cancer, but it’s important to note that we believe this phenomenon may occur in only a subset of colorectal cancer patients,” Khare says.

“We don’t yet know why this is the case, but we hope to determine if there is a correlation between the up-regulation of this gene and the life expectancy of patients with colorectal cancer. Future studies will help us understand who may be at risk, and ultimately, if personalized treatments can be planned to target this gene.”

The National Institutes of Health, a Veterans Affairs Merit Award, the MU Research Board Award and MU School of Medicine Bridge funded the work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.

This article was originally published on futurity.org
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 09, 2021
Cancer
Employing machine-learning to identify the biological languages of cancer and Alzheimer's
APR 09, 2021
Employing machine-learning to identify the biological languages of cancer and Alzheimer's
In a study published in the scientific journal PNAS, researchers from St. John's College and the  University of ...
MAY 06, 2021
Cancer
What accounts for the disparities in mortality rates from kidney cancer?
MAY 06, 2021
What accounts for the disparities in mortality rates from kidney cancer?
New research published in the journal Cancers attempts to address gaps in data regarding mortality risk from advanced-st ...
JUN 04, 2021
Cancer
Cancer patients with COVID-19 fare better with remote health monitoring
JUN 04, 2021
Cancer patients with COVID-19 fare better with remote health monitoring
A new study presented last week at the American Society of Clinical Oncology Annual Meeting after its publication in the ...
JUN 15, 2021
Cancer
Red seaweed consumption is associated with a low risk of colon cancer - but why?
JUN 15, 2021
Red seaweed consumption is associated with a low risk of colon cancer - but why?
New research published in Marine Drugs explains why diets high in red seaweed are associated with a low risk of col ...
Loading Comments...